A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants

The emergence of SARS-CoV-2 antigenic variants with increased transmissibility is a public health threat. Some variants show substantial resistance to neutralization by SARS-CoV-2 infection- or vaccination-induced antibodies. Here, we analyzed receptor binding domain-binding monoclonal antibodies de...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Aaron J., Turner, Jackson S., Liu, Zhuoming, Zhou, Julian Q., Aziati, Ishmael D., Chen, Rita E., Joshi, Astha, Bricker, Traci L., Darling, Tamarand L., Adelsberg, Daniel C., Altomare, Clara G., Alsoussi, Wafaa B., Case, James Brett, VanBlargan, Laura A., Lei, Tingting, Thapa, Mahima, Amanat, Fatima, Jeevan, Trushar, Fabrizio, Thomas, O’Halloran, Jane A., Shi, Pei-Yong, Presti, Rachel M., Webby, Richard J., Krammer, Florian, Whelan, Sean P.J., Bajic, Goran, Diamond, Michael S., Boon, Adrianus C.M., Ellebedy, Ali H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367776/
https://www.ncbi.nlm.nih.gov/pubmed/34464596
http://dx.doi.org/10.1016/j.immuni.2021.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367776/
https://www.ncbi.nlm.nih.gov/pubmed/34464596
http://dx.doi.org/10.1016/j.immuni.2021.08.013

Ejemplares similares